KR20170101998A - 혈청 유래 c형 간염 바이러스의 증식을 위해 이용되는 인간 지방 유래 줄기세포 및 그의 용도 - Google Patents

혈청 유래 c형 간염 바이러스의 증식을 위해 이용되는 인간 지방 유래 줄기세포 및 그의 용도 Download PDF

Info

Publication number
KR20170101998A
KR20170101998A KR1020177022015A KR20177022015A KR20170101998A KR 20170101998 A KR20170101998 A KR 20170101998A KR 1020177022015 A KR1020177022015 A KR 1020177022015A KR 20177022015 A KR20177022015 A KR 20177022015A KR 20170101998 A KR20170101998 A KR 20170101998A
Authority
KR
South Korea
Prior art keywords
hcv
cells
hadscs
hadsc
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020177022015A
Other languages
English (en)
Korean (ko)
Inventor
첸-룽 린
Original Assignee
프론티어 바이오-드러그 디벨롭먼트 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프론티어 바이오-드러그 디벨롭먼트 리미티드 filed Critical 프론티어 바이오-드러그 디벨롭먼트 리미티드
Publication of KR20170101998A publication Critical patent/KR20170101998A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/70—Non-animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24251—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G01N2333/186—Hepatitis C; Hepatitis NANB

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020177022015A 2015-01-07 2015-01-07 혈청 유래 c형 간염 바이러스의 증식을 위해 이용되는 인간 지방 유래 줄기세포 및 그의 용도 Withdrawn KR20170101998A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2015/070243 WO2016109947A1 (en) 2015-01-07 2015-01-07 Employing human adipose-derived stem cells to propagate serum-derived hepatitis c virus and use thereof

Publications (1)

Publication Number Publication Date
KR20170101998A true KR20170101998A (ko) 2017-09-06

Family

ID=56355408

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177022015A Withdrawn KR20170101998A (ko) 2015-01-07 2015-01-07 혈청 유래 c형 간염 바이러스의 증식을 위해 이용되는 인간 지방 유래 줄기세포 및 그의 용도

Country Status (10)

Country Link
US (1) US10273461B2 (enExample)
EP (1) EP3242932A4 (enExample)
JP (1) JP6670322B2 (enExample)
KR (1) KR20170101998A (enExample)
CN (1) CN107208060B (enExample)
AU (1) AU2015376561A1 (enExample)
CA (1) CA2973119A1 (enExample)
HK (1) HK1246824A1 (enExample)
TW (1) TWI616528B (enExample)
WO (1) WO2016109947A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL272145A (en) 2020-01-20 2021-07-29 Stem Cell Medicine Ltd Cosmetic compositions with protein concentrate from conditioned medium of adipose-derived stem cells
IL278473A (en) 2020-11-03 2022-06-01 Yeda Res & Dev Methods for diagnosing and determining treatment in multiple myeloma
CN114686517A (zh) * 2020-12-25 2022-07-01 中国医学科学院病原生物学研究所 一种hcv四受体转基因合并stat1敲除小鼠的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786207A (en) 1997-05-28 1998-07-28 University Of Pittsburgh Tissue dissociating system and method
CN1166773C (zh) 1997-12-02 2004-09-15 泽恩比奥公司 分离的人脂肪组织衍生的基质细胞
US6777231B1 (en) 1999-03-10 2004-08-17 The Regents Of The University Of California Adipose-derived stem cells and lattices
US20050076396A1 (en) 1999-03-10 2005-04-07 Katz Adam J. Adipose-derived stem cells and lattices
JP2009153383A (ja) * 2006-04-03 2009-07-16 Eci Inc 成熟肝細胞様細胞の製造方法
KR101224504B1 (ko) * 2010-10-01 2013-01-22 가톨릭대학교 산학협력단 크립토탄신온의 신규 용도
GB201119335D0 (en) * 2011-11-09 2011-12-21 Univ Leuven Kath Hepatitis virus infectable stem cells
US20140179775A1 (en) * 2012-02-29 2014-06-26 Mead Johnson Nutrition Company Neurogenesis screening method and uses thereof
US9402710B2 (en) * 2012-07-16 2016-08-02 The Board Of Trustees For The Leland Stanford Junior University Macroporous 3-D scaffolds for tissue engineering

Also Published As

Publication number Publication date
JP2018501820A (ja) 2018-01-25
EP3242932A4 (en) 2018-05-30
EP3242932A1 (en) 2017-11-15
WO2016109947A1 (en) 2016-07-14
HK1246824A1 (zh) 2018-09-14
JP6670322B2 (ja) 2020-03-18
US10273461B2 (en) 2019-04-30
US20180023058A1 (en) 2018-01-25
AU2015376561A1 (en) 2017-07-27
TWI616528B (zh) 2018-03-01
CN107208060A (zh) 2017-09-26
TW201625786A (zh) 2016-07-16
CA2973119A1 (en) 2016-07-14
CN107208060B (zh) 2021-06-18

Similar Documents

Publication Publication Date Title
Yu et al. Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2
Roelandt et al. Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus
Wu et al. Hepatic transforming growth factor beta gives rise to tumor‐initiating cells and promotes liver cancer development
Hassan et al. Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways
Li et al. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells
Yuan et al. A chimeric humanized mouse model by engrafting the human induced pluripotent stem cell-derived hepatocyte-like cell for the chronic hepatitis B virus infection
Li et al. Mesenchymal stem cells ameliorate hepatic ischemia/reperfusion injury via inhibition of neutrophil recruitment
Wang et al. TIM-1 promotes hepatitis C virus cell attachment and infection
CN106795489A (zh) 用于生产成人肝脏祖细胞的方法
Ranjan et al. Glycosylation of the laminin receptor (α3β1) regulates its association with tetraspanin CD151: Impact on cell spreading, motility, degradation and invasion of basement membrane by tumor cells
Azandeh et al. Improvement of mesenchymal stem cell differentiation into the endoderm lineage by four step sequential method in biocompatible biomaterial
Parent et al. An immortalized human liver endothelial sinusoidal cell line for the study of the pathobiology of the liver endothelium
CN111440800B (zh) 靶向Galectin-3基因的miRNA-128-3p及其抗胰腺癌的用途
Duss et al. Mesenchymal precursor cells maintain the differentiation and proliferation potentials of breast epithelial cells
US10273461B2 (en) Employing human adipose-derived stem cells to propagate serum-derived hepatitis C virus and use thereof
Banaudha et al. Primary hepatocyte culture supports hepatitis C virus replication: a model for infection‐associated hepatocarcinogenesis
KR102089477B1 (ko) 1차 인간 간세포의 표현형을 갖는 세포를 생성하기 위한 방법 및 조성물
WO2023180122A1 (en) Use of human allogenic liver-derived progenitor cells for treating and/or preventing cellular senescence
Kajimoto et al. Isolation and culture of microvascular endothelial cells from murine inguinal and epididymal adipose tissues
Lu et al. Tree shrew bone marrow–derived mesenchymal stem cells express CD81, OCLN, and miR‐122, facilitating the entire hepatitis C virus life cycle
JP2023546155A (ja) 尿由来の上皮細胞培養物、当該培養物由来の腎球体、ならびに当該腎球体の作製及び使用方法
CN106148337A (zh) 长非编码rna ay927503及其用途
Li et al. Mouse mesenchymal stem cells from bone marrow differentiate into smooth muscle cells by induction of plaque-derived smooth muscle cells
Gailhouste Isolation and purification method of mouse fetal hepatoblasts
Ramadan et al. Impact of hepatitis C virus-related liver cirrhosis on osteogenic gene expression and mineralization in bone marrow-derived mesenchymal stem cells

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20170807

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid